MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1
暂无分享,去创建一个
J. Cidlowski | J. Roa | P. Yankilevich | R. Oakley | M. Mercogliano | L. Venturutti | M. Rivas | Cecilia J. Proietti | D. H. Allemand | P. Guzmán | P. Elizalde | R. Schillaci | E. Cortese | F. Izzo | Martín A. Rivas | M. Pereyra | E. Charreau | C. Proietti | T. Huang | M. D. Martino | R. Russo | T. Huang | T. Huang | Franco Izzo | J. C. Roa | P. Guzmán | Robert H. Oakley | Matías G. Pereyra | Patricio Yankilevich | Eduardo Cortese | Daniel H. Allemand | Tim H M Huang | F. Izzo | P. Yankilevich